Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New cyclin-dependent kinase 9 inhibitors presented by Vichem Chemie Kutato

July 26, 2011

Novartis claims novel agents for treatment of cancer

July 26, 2011

CHMP issues opinion on Zytiga in prostate cancer

July 25, 2011

Afinitor recommended for new European approval

July 25, 2011

Tarceva recommended for E.U. approval as first-line therapy in distinct type of lung cancer

July 25, 2011

Celgene discloses novel inhibitors of TNF-alpha production and/or phosphodiesterase 4

July 25, 2011

Cellceutix cleared to conduct phase I trial of anticancer drug

July 22, 2011

NanoCarrier and Orient Europharma commence phase II study of Nanoplatin

July 22, 2011

Millennium files sNDA to add survival data to Velcade MM label in U.S.

July 22, 2011

S*BIO discloses novel mTOR inhibitors

July 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...